1-5 of 5
Da-Liang Ou
Close
Sort by
Journal Articles

Modulating Metabolic Reprogramming By Phosphoglycerate Dehydrogenase (PHGDH) Inhibitors in Omipalisib-Refractory AML

Chi-Yang Tseng, Yu-Hsuan Fu, Ching-Ying Kuo, Hsin-An Hou, Da-Liang Ou, Liang-In Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1432.
https://doi.org/10.1182/blood-2023-185713
Published: 2023
Journal Articles

Transcriptomic-Based in silico Drug Screening Reveals Dual PI3K/mTOR Inhibitors Overcome Cabozantinib-Resistance of FLT3 -ITD AML Cells

Chi-Yang Tseng, Yu-Hsuan Fu, Ang-Chu Huang, Da-Liang Ou, Ching-Ying Kuo, Liang-In Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 4947–4948.
https://doi.org/10.1182/blood-2022-163124
Published: 2022
Journal Articles

Strategies for Alleviating Tyrosine Kinase Resistance in Acute Myeloid Leukemia By Modulating p53 Signaling Pathway with Small Molecules

Chi-Yang Tseng, Fang-Yu Lo, Yu-Hsuan Fu, Da-Liang Ou, Hsin-An Hou, Liang-In Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 3086–3087.
https://doi.org/10.1182/blood-2022-163072
Published: 2022
Journal Articles

Metabolic Alterations May Contribute to Cabozantinib Resistance in Acute Myeloid Leukemia Cells with FLT3 -ITD

Fang-Yu Lo, Kit Man Ng, MS, Wen-Chun Chen, MS, Chung-Yi Hu, PhD, Hsin-An Hou, MD PhD, Cheng-Hong Tsai, MD, M.Sc., Da-Liang Ou, PhD, Hwei-Fang Tien, MD, PhD, Liang-In Lin, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2785.
https://doi.org/10.1182/blood-2018-99-118322
Published: 2018
Journal Articles

Pyrvinium Pamoate Overcomes Cabozantinib-Resistance of FLT3 -ITD AML Cells through Modulating the Mitochondria Functions and Signaling Pathways

Yu-Hsuan Fu, BS, Wen-Hui Lu, MS, Pei-Qi Lan, MS, Chung-Yi Hu, PhD, Chien-Yuan Chen, MD, PhD, Da-Liang Ou, PhD, Hwei-Fang Tien, MD, PhD, Liang-In Lin, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4683.
https://doi.org/10.1182/blood-2018-99-118476
Published: 2018